Artificial intelligence could be new blueprint for precision drug discovery
The Pharma Data
JULY 12, 2021
“This is mostly because drugs that work perfectly in preclinical inbred models, such as laboratory mice, that are genetically or otherwise identical to each other, don’t translate to patients in the clinic, where each individual and their disease is unique. HUMANOID Center of Research Excellence?(CoRE),
52 
Let's personalize your content